Harpoon Therapeutics Investor Relations Material
Latest events
Study Update
Harpoon Therapeutics
Corporate Presentation
1 Dec, 2023
Q3 2023
9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harpoon Therapeutics Inc
Access all reports
Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company engaged in the development of innovative T cell engagers. These engagers are designed to harness the power of the body's immune system to treat patients suffering from cancer and other diseases.The company is headquartered in South San Francisco, California, and its shares are listed on the Nasdaq.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
HARP
Country
🇺🇸 United States